LLY

981.86

-0.29%↓

JNJ

243.2

+0.67%↑

ABBV

221.94

+1.03%↑

NVS

154.64

+1.01%↑

AZN

192.02

+1%↑

LLY

981.86

-0.29%↓

JNJ

243.2

+0.67%↑

ABBV

221.94

+1.03%↑

NVS

154.64

+1.01%↑

AZN

192.02

+1%↑

LLY

981.86

-0.29%↓

JNJ

243.2

+0.67%↑

ABBV

221.94

+1.03%↑

NVS

154.64

+1.01%↑

AZN

192.02

+1%↑

LLY

981.86

-0.29%↓

JNJ

243.2

+0.67%↑

ABBV

221.94

+1.03%↑

NVS

154.64

+1.01%↑

AZN

192.02

+1%↑

LLY

981.86

-0.29%↓

JNJ

243.2

+0.67%↑

ABBV

221.94

+1.03%↑

NVS

154.64

+1.01%↑

AZN

192.02

+1%↑

Search

Simulations Plus Inc

Deschisă

SectorSănătate

12.19 -1.85

Rezumat

Modificarea prețului

24h

Curent

Minim

12.03

Maxim

12.52

Indicatori cheie

By Trading Economics

Venit

1.4M

676K

Vânzări

961K

18M

Randament dividend

0.48

Marjă de profit

3.67

Angajați

212

EBITDA

-3M

2.3M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+52.73% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.48%

2.40%

Următoarele câștiguri

2 apr. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-118M

250M

Deschiderea anterioară

14.04

Închiderea anterioară

12.19

Sentimentul știrilor

By Acuity

50%

50%

133 / 351 Clasament în Healthcare

Simulations Plus Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 mar. 2026, 21:14 UTC

Evenimente importante

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15 mar. 2026, 21:14 UTC

Evenimente importante

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16 mar. 2026, 00:00 UTC

Evenimente importante

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15 mar. 2026, 23:45 UTC

Market Talk

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15 mar. 2026, 23:44 UTC

Market Talk
Evenimente importante

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15 mar. 2026, 23:35 UTC

Market Talk
Evenimente importante

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15 mar. 2026, 23:00 UTC

Achiziții, Fuziuni, Preluări

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15 mar. 2026, 22:37 UTC

Market Talk

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15 mar. 2026, 22:18 UTC

Market Talk

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15 mar. 2026, 22:14 UTC

Câștiguri

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15 mar. 2026, 22:14 UTC

Câștiguri

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15 mar. 2026, 22:14 UTC

Câștiguri

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15 mar. 2026, 22:14 UTC

Câștiguri

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15 mar. 2026, 22:14 UTC

Câștiguri

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15 mar. 2026, 22:00 UTC

Evenimente importante

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mar. 2026, 22:00 UTC

Evenimente importante

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mar. 2026, 03:00 UTC

Evenimente importante

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14 mar. 2026, 15:00 UTC

Evenimente importante

Iran War Delivers Windfall to America's Oil Country -- WSJ

14 mar. 2026, 02:03 UTC

Câștiguri

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14 mar. 2026, 01:32 UTC

Achiziții, Fuziuni, Preluări

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14 mar. 2026, 00:29 UTC

Achiziții, Fuziuni, Preluări

13D Filings -- Barrons.com

13 mar. 2026, 22:27 UTC

Market Talk
Evenimente importante

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mar. 2026, 22:13 UTC

Market Talk
Evenimente importante

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mar. 2026, 22:04 UTC

Market Talk
Evenimente importante

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mar. 2026, 22:00 UTC

Achiziții, Fuziuni, Preluări

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mar. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

13 mar. 2026, 20:50 UTC

Market Talk
Evenimente importante

Financial Services Roundup: Market Talk

13 mar. 2026, 20:02 UTC

Market Talk

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mar. 2026, 19:50 UTC

Market Talk
Evenimente importante

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mar. 2026, 19:35 UTC

Evenimente importante

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Comparație

Modificare preț

Simulations Plus Inc Așteptări

Obiectiv de preț

By TipRanks

52.73% sus

Prognoză pe 12 luni

Medie 19 USD  52.73%

Maxim 19 USD

Minim 19 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruSimulations Plus Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

4 ratings

2

Cumpărare

2

Păstrare

0

Vânzare

Sentiment

By Acuity

133 / 351 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat